Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Prev Res (Phila). 2019 Feb 18;12(4):255–270. doi: 10.1158/1940-6207.CAPR-17-0356

Figure 6.

Figure 6

A. Molecular markers, combined with external and internal environment variables, can be used as biosocial markers of head and neck cancer outcome disparities, head and neck cancer markers and precision medicine markers for head and neck cancer patients. Figure 6B shows that PAX5 methylation levels inversely correlate (r=−0.83) with TIL counts in HNSCC patients. Figure 6C shows that JAK3 expression in Black HNSCC patients differs by anatomic location. Figure 6D shows that Notch1 mutations and PAX1 methylation levels also differ by anatomic location and race in HNSCC patients.